Sonoma Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

3. Summary of Significant Accounting Policies (Sept 2018 Note) (Tables)

3. Summary of Significant Accounting Policies (Sept 2018 Note) (Tables)

6 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

Schedule of antidilutive shares

		September 30,
		2018				2017
Restricted stock units			40,000				57,000
Options to purchase common stock			1,516,000				1,393,000
Warrants to purchase common stock			1,375,000				1,332,000
			2,931,000				2,782,000

Disaggregated Revenue by Source

		Three Months Ended September 30,								Six Months Ended September 30,
		2018				2017				2018				2017
Product
Human Skin Care		$	4,074,000			$	3,775,000			$	7,628,000			$	6,939,000
Animal Skin Care			561,000				369,000				1,102,000				808,000
			4,635,000				4,144,000				8,730,000				7,747,000
Service			304,000				181,000				578,000				413,000
Total		$	4,939,000			$	4,325,000			$	9,308,000			$	8,160,000